DePuy Synthes Builds Out Trauma Offering With TRS' 3D-Printed Tech
Underlining its focus on 3D-printing and the potential this technology can bring, DePuy Synthes has acquired the 3D-printed scaffold platform of Tissue Regeneration Systems, enabling the orthopedics leader to develop patient-specific trauma products in-house.
You may also be interested in...
M&A Analysis: April Showers Big Name Acquisitions
M&A deals rained down in April with the highest number of acquisitions of the year to date. The month saw 14 M&A deals, up by four from March's total, but still down from the 16 deals recorded in April 2016.
J&J Taps Aspect Biosystem's 3D Printing Tech For Meniscus Implant
3D bioprinting and tissue engineering specialist Aspect Biosystems has entered a research collaboration with Johnson & Johnson's DePuy Synthes to create bioprinted knee meniscus tissue suitable for surgical therapy. It is one of more than 50 commercial and academic partnerships J&J has entered to develop complementary technologies and materials for its medical devices.
J&J Announces New Device Collaborations
The Johnson & Johnson Innovation Center projects include a focus on solid-tumor resections, knee replacement procedures and atrial fibrillation ablation – as well as tracking down biomarkers tied to diabetes and prostate cancer.